At the World Summit on the Information Society, May 30, 2024, GCOA hosted a panel discussion on the global health crisis that is AMR and how technology can, should and will have an impact through diagnostics, surveillance, and innovative developments.  AMR will be responsible for 10 million deaths annually by 2050 – on track to…

At the meeting and in the report that followed, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration,” leaders called on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. They found…

Respiratory infections like influenza, RSV (respiratory syncytial virus), and now COVID-19, among others, place a substantial and growing burden on health systems. Among these three infections—responsible for the so called “tripledemic”—RSV is the least recognized. There is low awareness of RSV among healthcare professionals and the general public and little understanding of the disease burden…

On September 27, 2023, The Global Coalition on Aging (GCOA) Alliance for Health Innovation and The American Federation for Aging Research (AFAR) convened for a roundtable discussion on cancer, innovation, and healthy aging. Experts on cancer treatment, health policy, aging, and patient voices explored the value of biomedical innovation, and the importance of both the…

The new 2024 Progress Report assesses the same eleven countries as the 2021 Index: Brazil, Canada, China, France, Germany, India, Italy, Japan, South Korea, the United Kingdom (UK), and the United States (US). The 2021 Index examined over 100 metrics to evaluate and rank countries’ performance against AMR and establish benchmarks for policy action and…